{"entity":{"type":"insider","cik":"0001431441","url":"/insider/0001431441","json_url":"/insider/0001431441.json","name":"Clarus Ventures I, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":14,"first":"2010-07-15","last":"2015-06-17","span_basis":"filed_date"},"name_variants":[{"name":"Clarus Ventures I, LLC","source":"filing","n_filings":14,"first_seen":"2010-07-15","last_seen":"2015-06-17"}],"transactions":[{"id":8355423,"accession":"0001012975-15-000491","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000491","line_url":"/filing/0001012975-15-000491#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I Management, L.P.; HENNER DENNIS; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; WHEELER KURT; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"Clarus Ventures I Management, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39701.0,"shares_display":"39,701","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":567724.3,"total_display":"567,724.30","total_whole":"567,724","shares_owned_after":2237377.0,"shares_owned_after_display":"2,237,377","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-16","filed_date":"2015-06-17","scope":"insider"},{"id":8355417,"accession":"0001012975-15-000491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000491","line_url":"/filing/0001012975-15-000491#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I Management, L.P.; HENNER DENNIS; LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; WHEELER KURT; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"Clarus Ventures I Management, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1529.0,"shares_display":"1,529","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":21818.83,"total_display":"21,818.83","total_whole":"21,819","shares_owned_after":2277078.0,"shares_owned_after_display":"2,277,078","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-15","filed_date":"2015-06-17","scope":"insider"},{"id":8788735,"accession":"0001012975-15-000485","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000485","line_url":"/filing/0001012975-15-000485#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Lifesciences I, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"Clarus Lifesciences I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6430.0,"shares_display":"6,430","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":91627.5,"total_display":"91,627.50","total_whole":"91,628","shares_owned_after":2278607.0,"shares_owned_after_display":"2,278,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-12","filed_date":"2015-06-12","scope":"insider"},{"id":8788734,"accession":"0001012975-15-000485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000485","line_url":"/filing/0001012975-15-000485#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Lifesciences I, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"Clarus Lifesciences I, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25168.0,"shares_display":"25,168","price_per_share":14.27,"price_display":"14.27","price_state":"stated","total_value":359147.36,"total_display":"359,147.36","total_whole":"359,147","shares_owned_after":2285037.0,"shares_owned_after_display":"2,285,037","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-11","filed_date":"2015-06-12","scope":"insider"},{"id":8913883,"accession":"0001012975-15-000479","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8987.0,"shares_display":"8,987","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":128693.84,"total_display":"128,693.84","total_whole":"128,694","shares_owned_after":2310205.0,"shares_owned_after_display":"2,310,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-10","filed_date":"2015-06-10","scope":"insider"},{"id":8913880,"accession":"0001012975-15-000479","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13000.0,"shares_display":"13,000","price_per_share":14.26,"price_display":"14.26","price_state":"stated","total_value":185380.0,"total_display":"185,380.00","total_whole":"185,380","shares_owned_after":2319192.0,"shares_owned_after_display":"2,319,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-09","filed_date":"2015-06-10","scope":"insider"},{"id":8913878,"accession":"0001012975-15-000479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000479","line_url":"/filing/0001012975-15-000479#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; GALAKATOS NICHOLAS; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; Clarus Lifesciences I, L.P.","owner_display_name":"WHEELER KURT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2662.0,"shares_display":"2,662","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":37933.5,"total_display":"37,933.50","total_whole":"37,934","shares_owned_after":2332192.0,"shares_owned_after_display":"2,332,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-08","filed_date":"2015-06-10","scope":"insider"},{"id":8171549,"accession":"0001012975-15-000473","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10450.0,"shares_display":"10,450","price_per_share":14.32,"price_display":"14.32","price_state":"stated","total_value":149644.0,"total_display":"149,644.00","total_whole":"149,644","shares_owned_after":2334854.0,"shares_owned_after_display":"2,334,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-03","filed_date":"2015-06-03","scope":"insider"},{"id":8171546,"accession":"0001012975-15-000473","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11014.0,"shares_display":"11,014","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":156949.5,"total_display":"156,949.50","total_whole":"156,950","shares_owned_after":2345304.0,"shares_owned_after_display":"2,345,304","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-03","scope":"insider"},{"id":8171544,"accession":"0001012975-15-000473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000473","line_url":"/filing/0001012975-15-000473#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; WHEELER KURT; LIPTAK ROBERT; GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15010.0,"shares_display":"15,010","price_per_share":14.29,"price_display":"14.29","price_state":"stated","total_value":214492.9,"total_display":"214,492.90","total_whole":"214,493","shares_owned_after":2356318.0,"shares_owned_after_display":"2,356,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider"},{"id":8355363,"accession":"0001012975-15-000242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000242","line_url":"/filing/0001012975-15-000242#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; WHEELER KURT; Clarus Ventures I Management, L.P.; HENNER DENNIS; Simon Nicholas; Clarus Ventures I, LLC","owner_display_name":"LIPTAK ROBERT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26300.0,"shares_display":"26,300","price_per_share":14.44,"price_display":"14.44","price_state":"stated","total_value":379772.0,"total_display":"379,772.00","total_whole":"379,772","shares_owned_after":2371328.0,"shares_owned_after_display":"2,371,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-23","filed_date":"2015-03-24","scope":"insider"},{"id":8355356,"accession":"0001012975-15-000242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000242","line_url":"/filing/0001012975-15-000242#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"LIPTAK ROBERT; GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; WHEELER KURT; Clarus Ventures I Management, L.P.; HENNER DENNIS; Simon Nicholas; Clarus Ventures I, LLC","owner_display_name":"LIPTAK ROBERT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27115.0,"shares_display":"27,115","price_per_share":14.53,"price_display":"14.53","price_state":"stated","total_value":393980.95,"total_display":"393,980.95","total_whole":"393,981","shares_owned_after":2397628.0,"shares_owned_after_display":"2,397,628","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-24","scope":"insider"},{"id":8516808,"accession":"0001012975-15-000238","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-3","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50012.0,"shares_display":"50,012","price_per_share":14.61,"price_display":"14.61","price_state":"stated","total_value":730675.32,"total_display":"730,675.32","total_whole":"730,675","shares_owned_after":2424743.0,"shares_owned_after_display":"2,424,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-19","scope":"insider"},{"id":8516804,"accession":"0001012975-15-000238","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-2","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":14.68,"price_display":"14.68","price_state":"stated","total_value":367000.0,"total_display":"367,000.00","total_whole":"367,000","shares_owned_after":2474755.0,"shares_owned_after_display":"2,474,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-18","filed_date":"2015-03-19","scope":"insider"},{"id":8516797,"accession":"0001012975-15-000238","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-15-000238","line_url":"/filing/0001012975-15-000238#line-1","is_derivative":false,"issuer_cik":"0001249153","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001249153","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I, LLC; LIPTAK ROBERT; Clarus Lifesciences I, L.P.; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79307.0,"shares_display":"79,307","price_per_share":14.67,"price_display":"14.67","price_state":"stated","total_value":1163433.69,"total_display":"1,163,433.69","total_whole":"1,163,434","shares_owned_after":2499755.0,"shares_owned_after_display":"2,499,755","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-17","filed_date":"2015-03-19","scope":"insider"},{"id":2990177,"accession":"0001209191-12-041325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-12-041325","line_url":"/filing/0001209191-12-041325#line-2","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"GLOBUS MEDICAL INC","issuer_ticker":"GMED","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; LIPTAK ROBERT; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT; Clarus Lifesciences I, L.P.; STEINMETZ MICHAEL; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":804232.0,"shares_display":"804,232","price_per_share":11.16,"price_display":"11.16","price_state":"stated","total_value":8975229.12,"total_display":"8,975,229.12","total_whole":"8,975,229","shares_owned_after":7244201.0,"shares_owned_after_display":"7,244,201","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-08-08","filed_date":"2012-08-10","scope":"insider"},{"id":9080800,"accession":"0001012975-11-000265","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-11-000265","line_url":"/filing/0001012975-11-000265#line-1","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"Clarus Lifesciences I, L.P.; Clarus Ventures I, LLC; Clarus Ventures I Management, L.P.; HENNER DENNIS; WHEELER KURT; GALAKATOS NICHOLAS; LIPTAK ROBERT; STEINMETZ MICHAEL; Simon Nicholas","owner_display_name":"Clarus Lifesciences I, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500000.0,"shares_display":"3,500,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":9482439.0,"shares_owned_after_display":"9,482,439","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-09-16","filed_date":"2011-09-20","scope":"insider"},{"id":7160034,"accession":"0001181431-10-058220","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-10-058220","line_url":"/filing/0001181431-10-058220#line-4","is_derivative":false,"issuer_cik":"0001166285","issuer_name":"ZOGENIX, INC.","issuer_ticker":"ZGNX","issuer_name_source":null,"issuer_url":"/issuer/0001166285","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Simon Nicholas; Clarus Ventures I Management, L.P.; HENNER DENNIS; STEINMETZ MICHAEL; Clarus Lifesciences I, L.P.; LIPTAK ROBERT; Clarus Ventures I, LLC","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1750000.0,"shares_display":"1,750,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":7000000.0,"total_display":"7,000,000.00","total_whole":"7,000,000","shares_owned_after":5982439.0,"shares_owned_after_display":"5,982,439","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-29","filed_date":"2010-11-30","scope":"insider"},{"id":7378362,"accession":"0001012975-10-000397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000397","line_url":"/filing/0001012975-10-000397#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"STEINMETZ MICHAEL; Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures I GP, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS","owner_display_name":"STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1200000.0,"shares_display":"1,200,000","price_per_share":4.8116,"price_display":"4.81","price_state":"stated","total_value":5773920.0,"total_display":"5,773,920.00","total_whole":"5,773,920","shares_owned_after":6669216.0,"shares_owned_after_display":"6,669,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-09","filed_date":"2010-11-10","scope":"insider"},{"id":7378360,"accession":"0001012975-10-000397","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000397","line_url":"/filing/0001012975-10-000397#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"STEINMETZ MICHAEL; Clarus Ventures I, LLC; Clarus Lifesciences I, L.P.; Simon Nicholas; HENNER DENNIS; WHEELER KURT; Clarus Ventures I GP, L.P.; LIPTAK ROBERT; GALAKATOS NICHOLAS","owner_display_name":"STEINMETZ MICHAEL","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44626.0,"shares_display":"44,626","price_per_share":5.1,"price_display":"5.10","price_state":"stated","total_value":227592.6,"total_display":"227,592.60","total_whole":"227,593","shares_owned_after":7869216.0,"shares_owned_after_display":"7,869,216","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-08","filed_date":"2010-11-10","scope":"insider"},{"id":7399460,"accession":"0001012975-10-000385","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000385","line_url":"/filing/0001012975-10-000385#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; STEINMETZ MICHAEL; LIPTAK ROBERT; Clarus Ventures I, LLC; Clarus Ventures I GP, L.P.; WHEELER KURT; HENNER DENNIS; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":332572.0,"shares_display":"332,572","price_per_share":4.8031,"price_display":"4.80","price_state":"stated","total_value":1597376.5732,"total_display":"1,597,376.57","total_whole":"1,597,377","shares_owned_after":7913842.0,"shares_owned_after_display":"7,913,842","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-05","filed_date":"2010-11-05","scope":"insider"},{"id":7399456,"accession":"0001012975-10-000385","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000385","line_url":"/filing/0001012975-10-000385#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; STEINMETZ MICHAEL; LIPTAK ROBERT; Clarus Ventures I, LLC; Clarus Ventures I GP, L.P.; WHEELER KURT; HENNER DENNIS; Clarus Lifesciences I, L.P.; Simon Nicholas","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1400106.0,"shares_display":"1,400,106","price_per_share":4.5229,"price_display":"4.52","price_state":"stated","total_value":6332539.4274,"total_display":"6,332,539.43","total_whole":"6,332,539","shares_owned_after":8246414.0,"shares_owned_after_display":"8,246,414","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-03","filed_date":"2010-11-05","scope":"insider"},{"id":7723675,"accession":"0001012975-10-000382","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-10-000382","line_url":"/filing/0001012975-10-000382#line-3","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"HENNER DENNIS; WHEELER KURT; LIPTAK ROBERT; Clarus Ventures I GP, L.P.; Clarus Lifesciences I, L.P.; GALAKATOS NICHOLAS; STEINMETZ MICHAEL; Clarus Ventures I, LLC; Simon Nicholas","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1290871.0,"shares_display":"1,290,871","price_per_share":4.4934,"price_display":"4.49","price_state":"stated","total_value":5800399.7514,"total_display":"5,800,399.75","total_whole":"5,800,400","shares_owned_after":9646520.0,"shares_owned_after_display":"9,646,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-02","filed_date":"2010-11-02","scope":"insider"},{"id":7723673,"accession":"0001012975-10-000382","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000382","line_url":"/filing/0001012975-10-000382#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"HENNER DENNIS; WHEELER KURT; LIPTAK ROBERT; Clarus Ventures I GP, L.P.; Clarus Lifesciences I, L.P.; GALAKATOS NICHOLAS; STEINMETZ MICHAEL; Clarus Ventures I, LLC; Simon Nicholas","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2478142.0,"shares_display":"2,478,142","price_per_share":5.3562,"price_display":"5.36","price_state":"stated","total_value":13273424.1804,"total_display":"13,273,424.18","total_whole":"13,273,424","shares_owned_after":10937391.0,"shares_owned_after_display":"10,937,391","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-11-01","filed_date":"2010-11-02","scope":"insider"},{"id":7723671,"accession":"0001012975-10-000382","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000382","line_url":"/filing/0001012975-10-000382#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"HENNER DENNIS; WHEELER KURT; LIPTAK ROBERT; Clarus Ventures I GP, L.P.; Clarus Lifesciences I, L.P.; GALAKATOS NICHOLAS; STEINMETZ MICHAEL; Clarus Ventures I, LLC; Simon Nicholas","owner_display_name":"HENNER DENNIS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1424947.0,"shares_display":"1,424,947","price_per_share":5.0638,"price_display":"5.06","price_state":"stated","total_value":7215646.6186,"total_display":"7,215,646.62","total_whole":"7,215,647","shares_owned_after":13415533.0,"shares_owned_after_display":"13,415,533","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-29","filed_date":"2010-11-02","scope":"insider"},{"id":7359879,"accession":"0001012975-10-000362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-10-000362","line_url":"/filing/0001012975-10-000362#line-2","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; Clarus Ventures I GP, L.P.; Simon Nicholas; STEINMETZ MICHAEL; Clarus Ventures I, LLC; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":311000.0,"shares_display":"311,000","price_per_share":3.5159,"price_display":"3.52","price_state":"stated","total_value":1093444.9,"total_display":"1,093,444.90","total_whole":"1,093,445","shares_owned_after":14840480.0,"shares_owned_after_display":"14,840,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-11","filed_date":"2010-10-12","scope":"insider"},{"id":7359877,"accession":"0001012975-10-000362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000362","line_url":"/filing/0001012975-10-000362#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"GALAKATOS NICHOLAS; Clarus Lifesciences I, L.P.; Clarus Ventures I GP, L.P.; Simon Nicholas; STEINMETZ MICHAEL; Clarus Ventures I, LLC; LIPTAK ROBERT; WHEELER KURT; HENNER DENNIS","owner_display_name":"GALAKATOS NICHOLAS","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":240838.0,"shares_display":"240,838","price_per_share":3.4745,"price_display":"3.47","price_state":"stated","total_value":836791.631,"total_display":"836,791.63","total_whole":"836,792","shares_owned_after":15151480.0,"shares_owned_after_display":"15,151,480","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-10-08","filed_date":"2010-10-12","scope":"insider"},{"id":7132446,"accession":"0001012975-10-000250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-10-000250","line_url":"/filing/0001012975-10-000250#line-1","is_derivative":false,"issuer_cik":"0000858803","issuer_name":"AVANIR PHARMACEUTICALS, INC.","issuer_ticker":"AVNR","issuer_name_source":null,"issuer_url":"/issuer/0000858803","owner_cik":null,"owner_name":"Clarus Ventures I, LLC; HENNER DENNIS; WHEELER KURT; LIPTAK ROBERT; Simon Nicholas; Clarus Lifesciences I, L.P.; GALAKATOS NICHOLAS; Clarus Ventures I GP, L.P.; STEINMETZ MICHAEL","owner_display_name":"Clarus Ventures I, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":165000.0,"shares_display":"165,000","price_per_share":3.5342,"price_display":"3.53","price_state":"stated","total_value":583143.0,"total_display":"583,143.00","total_whole":"583,143","shares_owned_after":15392318.0,"shares_owned_after_display":"15,392,318","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-07-13","filed_date":"2010-07-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001586049","name":"Oxford Immunotec Global PLC","url":"/issuer/0001586049","role":"Ten percent owner","n_filings":6,"first_seen":"2015-03-19","last_seen":"2015-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001237831","name":"GLOBUS MEDICAL INC","url":"/issuer/0001237831","role":"Other","n_filings":1,"first_seen":"2012-08-10","last_seen":"2012-08-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner","n_filings":2,"first_seen":"2010-11-30","last_seen":"2011-09-20"},{"type":"issuer","type_label":"ISSUER","cik":"0000858803","name":"AVANIR PHARMACEUTICALS, INC.","url":"/issuer/0000858803","role":"Ten percent owner","n_filings":5,"first_seen":"2010-07-15","last_seen":"2010-11-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001431441","retrieved_at":"2026-08-23T14:32:58+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}